
Sign up to save your podcasts
Or


In this episode, we’re talking money.
The guests in this discussion recognize that the economic climate has been different (and more chaotic) in last three to four months, but expect a steady but slow improvement as we move into the new year.
This episode reviews 2024’s investment landscape and the policies influencing investment going into 2025.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Konstantina Katcheves, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals
Sanskriti Thakur, Chairwoman, TOWER Capital
By BioSpace4.9
1313 ratings
In this episode, we’re talking money.
The guests in this discussion recognize that the economic climate has been different (and more chaotic) in last three to four months, but expect a steady but slow improvement as we move into the new year.
This episode reviews 2024’s investment landscape and the policies influencing investment going into 2025.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Konstantina Katcheves, Senior Vice President, Innovative Medicines Global Business Development and Acquisitions, Teva Pharmaceuticals
Sanskriti Thakur, Chairwoman, TOWER Capital

91,010 Listeners

30,856 Listeners

43,717 Listeners

8,777 Listeners

962 Listeners

4,361 Listeners

1,177 Listeners

1,986 Listeners

56,898 Listeners

9,564 Listeners

334 Listeners

6,083 Listeners

6,562 Listeners

35 Listeners

21 Listeners